Linked Life Data

16107149

Source:http://linkedlifedata.com/resource/pubmed/id/16107149

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16107149rdf:typepubmed:Citationlld:pubmed
pubmed-article:16107149lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C0042774lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:16107149lifeskim:mentionsumls-concept:C1611082lld:lifeskim
pubmed-article:16107149pubmed:issue17lld:pubmed
pubmed-article:16107149pubmed:dateCreated2005-8-18lld:pubmed
pubmed-article:16107149pubmed:abstractTextThe pyrimidine nucleoside beta-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine (1) was designed as a hepatitis C virus RNA-dependent RNA polymerase (HCV RdRp) inhibitor. The title compound was obtained by a DAST fluorination of N(4)-benzoyl-1-(2-methyl-3,5-di-O-benzoyl-beta-d-arabinofuranosyl]cytosine to provide N(4)-benzoyl-1-[2-fluoro-2-methyl-3,5-di-O-benzoyl-beta-d-ribofuranosyl]cytosine. The protected 2'-C-methylcytidine was obtained as a byproduct from the DAST fluorination and allowed for the preparation of two biologically active compounds from a common precursor. Compound 1 and 2'-C-methylcytidine were assayed in a subgenomic HCV replicon assay system and found to be potent and selective inhibitors of HCV replication. Compound 1 shows increased inhibitory activity in the HCV replicon assay compared to 2'-C-methylcytidine and low cellular toxicity.lld:pubmed
pubmed-article:16107149pubmed:languageenglld:pubmed
pubmed-article:16107149pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16107149pubmed:citationSubsetIMlld:pubmed
pubmed-article:16107149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16107149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16107149pubmed:statusMEDLINElld:pubmed
pubmed-article:16107149pubmed:monthAuglld:pubmed
pubmed-article:16107149pubmed:issn0022-2623lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:StecWojciech...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:SchinaziRaymo...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:PankiewiczKrz...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:WatanabeKyoic...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:PattersonStev...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:OttoMichael...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:FurmanPhillip...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:StuyverLieven...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:LostiaStefani...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:TharnishPhill...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:McBrayerTamar...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:ClarkJeremy...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:HolleckerLaur...lld:pubmed
pubmed-article:16107149pubmed:authorpubmed-author:MasonJ...lld:pubmed
pubmed-article:16107149pubmed:issnTypePrintlld:pubmed
pubmed-article:16107149pubmed:day25lld:pubmed
pubmed-article:16107149pubmed:volume48lld:pubmed
pubmed-article:16107149pubmed:ownerNLMlld:pubmed
pubmed-article:16107149pubmed:authorsCompleteYlld:pubmed
pubmed-article:16107149pubmed:pagination5504-8lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:meshHeadingpubmed-meshheading:16107149...lld:pubmed
pubmed-article:16107149pubmed:year2005lld:pubmed
pubmed-article:16107149pubmed:articleTitleDesign, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.lld:pubmed
pubmed-article:16107149pubmed:affiliationPharmasset, Inc., 303-A College Road East, Princeton, New Jersey 08540, USA.lld:pubmed
pubmed-article:16107149pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16107149lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16107149lld:pubmed